A phase 1b/2b multicenter study of oral panobinostat plus azacitidine in adults with MDS, CMML or AML with< 30% blasts

Garcia-Manero, G.Sekeres, M. A.Egyed, MiklósBreccia, M.Graux, C.Cavenagh, J. D.Salman, H.Illés, ÁrpádFenaux, PierreDeAngelo, D. J.Stauder, R.Yee, K.Zhu, N.Lee, J. H.Valcarcel, D.MacWhannell, A.Borbényi, ZitaGazi, L.Acharyya, S.Ide, S.Marker, M.Ottmann, O. G.2017-08-032017-08-032017Leukemia. - 31 : 12 (2017), p. 2799-2806. -Leukemia. - 0887-69240887-6924http://hdl.handle.net/2437/242857A phase 1b/2b multicenter study of oral panobinostat plus azacitidine in adults with MDS, CMML or AML with< 30% blastsfolyóiratcikkopen access pre-print és post-printhttp://webpac.lib.unideb.hu:8082/ebib/CorvinaWeb?action=cclfind&resultview=long&ccltext=idno+BIBFORM070026OrvostudományokKlinikai orvostudományokNature Publishing Grouphttp://dx.doi.org/10.1038/leu.2017.1596 hónaphttps://www.nature.com/articles/leu20171592021-03-09